AQB
AQB
NASDAQ · Biotechnology

Aquabounty Technologies

$1.09
-0.01 (-0.91%)
As of Jun 29, 10:46 PM ET ·
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 38%
Sell 5 63%
Price Target
Analyst Price Target +1,834.9% upside
Low Target $14.27
Average Target $21.09
High Target $34.90
Current Price $1.09
Current
$1.09
Target
$21.09
$14.27 $21.09 avg $34.90
Scenario Analysis
Bear Case
$14.27
1,209.2%
Low target
Base Case
$21.09
+1,834.9%
Avg target
Bull Case
$34.90
+3,101.8%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$2.95
-63.1% from high
52-Week Low
$0.70
+55.7% from low
Target vs 52W High
$21.09
+614.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.1%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -12.3%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.1%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.5%